Long-term Care

Long-term care covers two forms of support, homes under the Korian brand (Germany, France, Belgium, Italy, Netherlands), Senior Residencias (Spain) and Rosorum (Netherlands), and shared living solutions, including shared housing. Clariane’s expertise ensures that its care homes are protected and tailored to each situation, making them places of conviviality and sharing.

Medicalised nursing homes are specialty facilities offering accommodation and care for vulnerable older people. These facilities offer both long-term care and short respite stays, including day care in some cases. Dedicated to the elderly and situations of great dependency, in particular cognitive dependency (Alzheimer’s disease and related disorders), these Group facilities offer permanent stays, short-term stays, and day care services. Rooted in the regions where they are located, the Clariane Group’s care homes work in close collaboration with the local health and social ecosystem.

Shared living solutions, for their part, meet the aspirations of new generations of senior citizens in terms of care and support. They include living solutions such as the Âges & Vie shared houses in France, assisted living and domiciliary care.

Our mission is to take care of each person’s humanity in times of vulnerability. It reflects our ambition to reinvent support for older people by placing human connection, dignity and quality of life at the heart of care, whether in our care homes or through innovative shared housing solutions.

Sophie Boissard CEO of Clariane

Key figures

  • 656

    medicalised nursing homes

  • 61789

    beds across our medicalised nursing homes

  • 280

    alternative living facilities

    • shared houses
    • assisted living
  • 13343 beds

    across our alternative living facilities

  • 76%

    of the Group’s total revenue

Industry trends

Four structural trends are confirming the growing importance of tailored service offerings for older and vulnerable people. Chronic diseases, population ageing, the digitalisation of healthcare and the desire to age at home are reshaping needs and expectations in terms of care and support.

As the leading European community for healthcare, Clariane is committed to delivering human-centred and innovative solutions to address these challenges throughout the life course.

  1. Chronic diseases: Chronic diseases — in particular cardiovascular diseases, cancer, diabetes and long-term respiratory conditions — are now the leading cause of death and disability in Europe. According to the World Health Organization, non-communicable diseases account for around 1.8 million avoidable deaths each year across the continent. In 2023, more than one third of adults in the European Union reported living with a chronic disease or long-term health problem.
  2. Ageing population: Population ageing is a major demographic trend shaping healthcare systems in Europe. The proportion of people aged 65 and over continues to increase, driven by rising life expectancy and persistently low fertility rates. In the European Union, this share is expected to rise from 21.6% in 2024 to 24.2% by 2030, reaching 30.6% by 2050.
  3. Digitalisation of healthcare: The digital transformation of healthcare is redefining access to and the quality and efficiency of care in Europe. Telemedicine accounted for nearly 16% of medical consultations in 2022 on average across European countries, facilitating faster access to healthcare professionals. Electronic health records strengthen continuity of care and coordination between professionals. Artificial intelligence is opening new perspectives in personalised prevention, chronic disease monitoring and innovation in patient care.
  4. Domiciliary care: The desire to age at home has been a major trend in Europe for more than twenty years. Driven by baby boomers’ aspiration for independence, this evolution reflects the desire to preserve one’s lifestyle, social ties and familiar environment.

Our locations

A French group founded in 2003, Clariane has rapidly expanded its operations across Europe, with acquisitions in Italy and Germany in 2007, Belgium in 2013, and Spain and the Netherlands in 2019.

Find out more

Our fundamentals

Also read